Endovascular management of chronic symptomatic aortic dissection with the Streamliner Multilayer Flow Modulator: Twelve-month outcomes from the global registry.

摘要: Abstract Objective Reported are initial 12-month outcomes of patients with chronic symptomatic aortic dissection managed by the Streamliner Multilayer Flow Modulator (SMFM; Cardiatis, Isnes, Belgium). Primary end points were freedom from rupture- and aortic-related death, reduction in false lumen index. Secondary patency great vessels visceral branches, stroke, paraplegia, renal failure. Methods Out 876 SMFM implanted globally, we have knowledge 542. To date, 312 maintained global registry, which 38 identified as having an (12.2%). Indications included 35 Stanford type B dissections, two A one mycotic dissection. Results There no reported ruptures or deaths. All cause survival was 85.3% Twelve-month neurologic events 100%, there incidences end-organ ischemia, paraplegia insult. Morphologic analysis exhibited remodeling a longitudinal length dissected aorta, volume. statistically significant index ( P  = .016) at 12 months, borderline increase true volume .053) confirmed remodeling. Conclusions The is option management complex pan-aortic highlight implantation leads to stabilization further aneurysm progression, retrograde Thoracic endovascular repair ensued rupture, Further registry data will inform long-term outcomes.